| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |